Comera Life Sciences Holdings, Inc. (CMRA)
OTCMKTS · Delayed Price · Currency is USD
0.0002
+0.0001 (100.00%)
At close: Oct 25, 2024

CMRA Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2022 FY 2021 FY 2020
Period Ending
Sep '23 Dec '22 Dec '21 Dec '20
Net Income
-9.01-18-5.45-2.13
Depreciation & Amortization
0.10.090.090.09
Loss (Gain) From Sale of Assets
---0
Stock-Based Compensation
10.381.110.27
Other Operating Activities
-0.165.21-0.08-
Change in Accounts Receivable
0.29-0.030.11-0.11
Change in Accounts Payable
-0.40.860.320.02
Change in Unearned Revenue
-0.14-0.03-0.03
Change in Other Net Operating Assets
1.521.580.170.08
Operating Cash Flow
-6.66-9.77-3.76-1.8
Capital Expenditures
-0.09-0.03-0.14-0.01
Investing Cash Flow
-0.09-0.03-0.14-0.01
Short-Term Debt Issued
--0.75-
Long-Term Debt Issued
---0.16
Total Debt Issued
--0.750.16
Short-Term Debt Repaid
--1.06--
Total Debt Repaid
-1.17-1.06--
Net Debt Issued (Repaid)
-1.17-1.060.750.16
Issuance of Common Stock
5.974.80.181.39
Other Financing Activities
1.511.51--
Financing Cash Flow
5.855.2410.281.55
Net Cash Flow
-0.9-4.566.38-0.26
Free Cash Flow
-6.76-9.8-3.9-1.82
Free Cash Flow Margin
-675.24%-1547.99%-1219.38%-410.11%
Free Cash Flow Per Share
-0.35-0.94-1.29-0.16
Levered Free Cash Flow
-2.99-4.98-1.83-
Unlevered Free Cash Flow
-2.97-4.97-1.83-
Change in Net Working Capital
-0.8-1.13-0.57-
Source: S&P Capital IQ. Standard template. Financial Sources.